HealthEquity (HQY) Q4 2026 Annual Earnings
HealthEquity reported Q4 2026 revenue of $334.6M (+7.3% YoY), beat analyst consensus of $332.3M by $2.3M. Diluted EPS came in at $0.95 (+37.7% YoY), beat the $0.89 consensus by $0.06.
Financial Snapshot
Trailing eight quarters through Q4 2026
Q4 2026 Earnings FAQ
Common questions about HealthEquity's Q4 2026 earnings report.
HealthEquity (HQY) reported Q4 2026 earnings on March 17, 2026 after market close.
HealthEquity reported revenue of $334.6M and diluted EPS of $0.95 for Q4 2026.
Revenue beat the consensus estimate of $332.3M by $2.3M. EPS beat the consensus estimate of $0.89 by $0.06.
Compared to the same quarter a year prior, revenue grew 7.3% from $311.8M a year earlier and diluted EPS grew 37.7% from $0.69.
You can read the 8-K earnings release (0001428336-26-000009) and the 10-K periodic report (0001428336-26-000010) directly on SEC EDGAR. The filing index links above go to sec.gov.